| Members |
targetComponentId |
| Poisoning: [antineoplastic] &/or [immunosuppressive] |
Antineoplastic adverse reaction |
| Poisoning: [antineoplastic] &/or [immunosuppressive] |
Antineoplastic overdose |
| Poisoning: [psychostimulant] or [stimulant] |
Psychostimulant overdose |
| Poisoning: [water, mineral and urate metabolism] or [diuretic] |
Diuretic overdose |
| Poisoning: [water, mineral and urate metabolism] or [diuretic] |
Diuretic adverse reaction (disorder) |
| ringe sociale forhold |
Social context finding |
| ringe sociale forhold |
Social and personal history finding |
| popliteal |
Popliteal region structure |
| Meatografi med positiv kontrast |
Computed tomography of internal auditory meatus with contrast (procedure) |
| Meatografi med positiv kontrast |
Magnetic resonance imaging of internal auditory meatus with contrast (procedure) |
| posterior aksillær |
Axillary region structure |
| posterior aksillær |
Posterior axillary fold structure |
| postoperativ pankreatografi |
Fluoroscopic pancreatography with contrast (procedure) |
| postoperativ pankreatografi |
Magnetic resonance imaging of pancreas with contrast (procedure) |
| postoperativ pankreatografi |
Endoscopic retrograde pancreatography |
| postoperativ pankreatografi |
Computed tomography of pancreas with contrast (procedure) |
| postoperativ pankreatografi |
Imaging of pancreas with contrast (procedure) |
| kalium i prøve |
Potassium level - finding |
| forgiftning med kaliumbesparende diuretikum |
Potassium sparing diuretic adverse reaction |
| forgiftning med kaliumbesparende diuretikum |
Potassium sparing diuretic overdose |
| forgiftning med kaliumbesparende diuretikum, uvist med hvilken hensigt |
Potassium sparing diuretic adverse reaction |
| forgiftning med kaliumbesparende diuretikum, uvist med hvilken hensigt |
Potassium sparing diuretic overdose |
| Presenting complaint |
Chief complaint (observable entity) |
| Presenting complaint |
Chief complaint section (record artifact) |
| Presenting complaint |
Chief complaint (observable entity) |
| Presenting complaint |
Chief complaint section (record artifact) |
| Presenting complaint |
Chief complaint (observable entity) |
| Presenting complaint |
Chief complaint section (record artifact) |
| Primary malignant neoplasm of breast with axillary lymph node invasion |
Primary malignant neoplasm of breast (disorder) |
| Primary malignant neoplasm of breast with axillary lymph node invasion |
Metastatic malignant neoplasm to axillary lymph nodes |
| dissemineret ovariecancer |
Primary malignant neoplasm of ovary |
| dissemineret ovariecancer |
Widespread metastatic malignant neoplastic disease (disorder) |
| Primary malignant neoplasm of prostate metastatic to bone |
Metastatic malignant neoplasm to bone |
| Primary malignant neoplasm of prostate metastatic to bone |
Primary malignant neoplasm of prostate |
| Primary malignant neoplasm of rectosigmoid junction metastatic to brain |
Primary malignant neoplasm of rectosigmoid junction |
| Primary malignant neoplasm of rectosigmoid junction metastatic to brain |
Metastatic malignant neoplasm to brain |
| thyroideacancer med metastasering til knogle |
Metastatic malignant neoplasm to bone |
| thyroideacancer med metastasering til knogle |
Primary malignant neoplasm of thyroid gland |
| dissemineret vulvacancer |
Widespread metastatic malignant neoplastic disease (disorder) |
| dissemineret vulvacancer |
Primary malignant neoplasm of vulva |
| Problem related to social environment |
Social context finding |
| Problem related to social environment |
Social and personal history finding |
| Problem related to social environment |
Social environment related disease |
| Procedure aiding diagnosis |
Procedure |
| Procedure aiding diagnosis |
Determination of a value, conclusion, or inference by evaluating evidence |
| procedure, der letter diagnose |
Procedure |
| procedure, der letter diagnose |
Determination of a value, conclusion, or inference by evaluating evidence |
| indgreb relateret til kirurgisk arteriovenøs tilslutning |
Arteriovenous fistula operation |
| indgreb relateret til kirurgisk arteriovenøs tilslutning |
Arteriovenous anastomosis (procedure) |
| indgreb relateret til kirurgisk arteriovenøs tilslutning |
Procedure on blood vessel |
| Product containing aspirin and isosorbide (medicinal product) |
Product containing aspirin and isosorbide mononitrate (medicinal product) |
| ormemiddel indeholdende benzimidazol |
Benzimidazole (substance) |
| ormemiddel indeholdende benzimidazol |
Anthelmintic |
| Rh anti-D immunglobulin |
Product containing human anti-D immunoglobulin (medicinal product) |
| Product containing blood group antibody D in parenteral dose form (medicinal product form) |
Product containing human anti-D immunoglobulin in parenteral dose form (medicinal product form) |
| kollodiumprodukt |
A liquid dose form consisting of active substance(s) in a mixture of pyroxylin or similar in ether and ethanol. |
| diamidinantiprotozomiddel |
Antiprotozoal |
| diamidinantiprotozomiddel |
Diamidine (substance) |
| dichloracetamidantiprotozomiddel |
Dichloroacetamide (substance) |
| dichloracetamidantiprotozomiddel |
Antiprotozoal |
| Product containing hydralazine and isosorbide |
Product containing hydralazine and isosorbide dinitrate (medicinal product) |
| Product containing hydralazine and isosorbide in oral dose form (medicinal product form) |
Hydralazine- and isosorbide dinitrate-containing product in oral dose form |
| hydroxyquinolinantiprotozomiddel |
Antiprotozoal |
| hydroxyquinolinantiprotozomiddel |
Oxyquinoline |
| Product containing isosorbide in oromucosal dose form (medicinal product form) |
Isosorbide dinitrate-containing product in oromucosal dose form |
| Product containing isosorbide in oropharyngeal dose form (medicinal product form) |
Isosorbide dinitrate-containing product in oromucosal dose form |
| Product containing isosorbide in parenteral dose form (medicinal product form) |
Isosorbide dinitrate-containing product in parenteral dose form |
| Product containing isosorbide in sublingual dose form (medicinal product form) |
Isosorbide dinitrate-containing product in oromucosal dose form |
| Product containing isosorbide in transdermal dose form (medicinal product form) |
Isosorbide dinitrate-containing product in transdermal dose form |
| Product containing only aspirin and isosorbide (medicinal product) |
Aspirin and isosorbide mononitrate only product |
| Product containing only blood group antibody D (medicinal product) |
Product containing only human anti-D immunoglobulin in parenteral dose form (medicinal product form) |
| Product containing only blood group antibody D in parenteral dose form (medicinal product form) |
Product containing only human anti-D immunoglobulin in parenteral dose form (medicinal product form) |
| Product containing only collodion (medicinal product) |
A liquid dose form consisting of active substance(s) in a mixture of pyroxylin or similar in ether and ethanol. |
| Product containing only hydralazine and isosorbide (medicinal product) |
Product containing only hydralazine and isosorbide dinitrate (medicinal product) |
| Product containing only hydralazine and isosorbide in oral dose form (medicinal product form) |
Product containing only hydralazine and isosorbide dinitrate in oral dose form (medicinal product form) |
| Product containing only isosorbide in oromucosal dose form (medicinal product form) |
Isosorbide dinitrate only product in oromucosal dose form |
| Product containing only isosorbide in parenteral dose form (medicinal product form) |
Isosorbide dinitrate only product in parenteral dose form |
| Product containing only isosorbide in transdermal dose form (medicinal product form) |
Isosorbide dinitrate only product in transdermal dose form |
| amitriptylin 12,5 mg + chlordiazepoxid 10 mg tablet |
Amitriptyline (as amitriptyline hydrochloride) 12.5 mg and chlordiazepoxide 10 mg oral tablet |
| amitriptylinhydrochlorid 12,5 mg + chlordiazepoxid 5 mg tablet |
Product containing precisely amitriptyline (as amitriptyline hydrochloride) 12.5 milligram and chlordiazepoxide 5 milligram/1 each conventional release oral tablet (clinical drug) |
| Product containing precisely blood group antibody D 1136 unit/1 milliliter conventional release solution for injection (clinical drug) |
Product containing precisely human anti-D immunoglobulin 1136.364 unit/1 milliliter conventional release solution for injection (clinical drug) |
| Product containing precisely haloperidol (as haloperidol decanoate) 100 milligram/1 milliliter prolonged-release oil for injection (clinical drug) |
Product containing precisely haloperidol (as haloperidol decanoate) 100 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| Product containing precisely haloperidol (as haloperidol decanoate) 100 milligram/1 milliliter prolonged-release oil for injection ampule |
Product containing precisely haloperidol (as haloperidol decanoate) 100 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| Product containing precisely haloperidol (as haloperidol decanoate) 50 milligram/1 milliliter prolonged-release oil for injection (clinical drug) |
Product containing precisely haloperidol (as haloperidol decanoate) 50 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| Product containing precisely haloperidol (as haloperidol decanoate) 50 milligram/1 milliliter prolonged-release oil for injection ampule |
Product containing precisely haloperidol (as haloperidol decanoate) 50 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| methylergometrinmaleat 20 µg tablet |
Product containing precisely methylergometrine maleate 200 microgram/1 each conventional release oral tablet (clinical drug) |
| Product containing precisely phenol 1.25 gram/25 milliliter prolonged-release oil for injection vial |
Phenol 50 mg/mL solution for injection |
| Product containing precisely phenol 50 milligram/1 milliliter prolonged-release oil for injection (clinical drug) |
Phenol 50 mg/mL solution for injection |
| Product containing precisely triptorelin 11.25 milligram/1 vial powder for conventional release suspension for injection |
Product containing precisely triptorelin (as triptorelin pamoate) 11.25 milligram/1 vial powder for conventional release suspension for injection (clinical drug) |
| antegrad peroperativ pankreatografi |
Endoscopic retrograde pancreatography |
| antegrad peroperativ pankreatografi |
Computed tomography of pancreas with contrast (procedure) |
| antegrad peroperativ pankreatografi |
Fluoroscopic pancreatography with contrast (procedure) |
| antegrad peroperativ pankreatografi |
Imaging of pancreas with contrast (procedure) |
| antegrad peroperativ pankreatografi |
Magnetic resonance imaging of pancreas with contrast (procedure) |
| olie til injektion |
Prolonged-release solution for injection (dose form) |
| olie til injektion |
Solution for injection |
| prostatisk |
Prostate |
| mental funktion |
Mental function (observable entity) |
| mental funktion |
Psychological function |
| Psychostimulant poisoning NOS |
Psychostimulant overdose |
| pulmonal |
Pulmonary structure including vessels and lymphoid tissue |
FHIR